Please Wait
Applying Filters...
menu
    • menu
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Ethypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    Menu

    Mesdopetam

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    IRLAB Granted Patent for Mesdopetam Candidate in China
    IRLAB Granted Patent for Mesdopetam Candidate in China

    04 Sep 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/irlab-is-granted-a-patent-strengthening-the-market-exclusivity-of-the-1068710

    ACCESSWIRE
    04 Sep 2025
    Share Share
    IRLAB Publishes Ph 2b Mesdopetam Data In Movement Disorders
    IRLAB Publishes Ph 2b Mesdopetam Data In Movement Disorders

    27 Feb 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/irlab-publishes-phase-iib-data-on-mesdopetam-in-movement-disorders-cli-992587

    ACCESSWIRE
    27 Feb 2025
    Share Share
    Irlab Gets EMA Waiver For Pediatric Mesdopetam Parkinson’s Studies
    Irlab Gets EMA Waiver For Pediatric Mesdopetam Parkinson’s Studies

    23 Jan 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/irlab-has-received-a-waiver-from-the-ema-regarding-pediatric-studies-w-972627

    ACCESSWIRE
    23 Jan 2025
    Share Share
    IRLAB Reports Progress Ahead of Mesdopetam Phase III Program
    IRLAB Reports Progress Ahead of Mesdopetam Phase III Program

    29 Oct 2024

    // ACCESSWIRE

    https://www.accesswire.com/936480/irlab-reports-continued-progress-ahead-of-the-mesdopetam-phase-iii-program

    ACCESSWIRE
    29 Oct 2024
    Share Share
    IRLAB Receives End-of-Ph 2 Meeting Confirming Alignment with the FDA
    IRLAB Receives End-of-Ph 2 Meeting Confirming Alignment with the FDA

    22 Mar 2024

    // ACCESSWIRE

    https://www.accesswire.com/845836/irlab-receives-minutes-from-end-of-phase-2-meeting-confirming-alignment-with-the-fda-on-the-phase-iii-program-for-mesdopetam

    ACCESSWIRE
    22 Mar 2024
    Share Share
    IRLAB Provides Update on Mesdopetam's Phase IIb Study Data
    IRLAB Provides Update on Mesdopetam's Phase IIb Study Data

    21 Aug 2023

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=775597&lang=en

    ACCESSWIRE
    21 Aug 2023
    Share Share